Ex SVP, DPU Head, In-Silico Discovery, GSK Pharmaceuticals
Headed innovative drug discovery unit dedicated to explore and apply in silico methodology to drug discovery and development at GSK.
This followed his role as Senior Vice President, Platform Technology and Science (PTS), GSK Pharma R&D.
Joined GSK in 1989 and worked in the pharmaceutical industry for 42 years. His experience spans new chemical entity design, development and commercialization, and biopharmaceutical development.
Held various positions at GSK including Senior Vice President, Preclinical Development; Vice President, Product Development; Director, Product Development; and Assistant Director, Biopharmaceutical Formulation Development, among others.
Led several key cross-functional problem solving and strategic initiatives.
BS in biochemistry (1974), and MS and Ph.D. degrees in chemistry (1980) from Penn State University.